Chargement en cours...
Cetuximab in Refractory Skin Cancer Treatment
Objectives: Non-melanoma skin cancer is the most common malignancy in US, with an annual incidence of in excess of 1.5 million cases. In the majority of cases, locoregional treatment is curative and systemic therapy is not indicated. Platinum-based chemotherapy regimens have been used most commonly...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Ivyspring International Publisher
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3376776/ https://ncbi.nlm.nih.gov/pubmed/22712026 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.3491 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|